Share
27,397 Posts.
lightbulb Created with Sketch. 1781
clock Created with Sketch. 02/11/19
17:51
Share
Originally posted by suzuki42
↑
Really I think AHZ are on the right path now costs are down and AHZ has the necessary funds to do the initial human trials for the TAVR . Most here doubted the tech and its value but I have never doubted it . WP surprised everyone with the Cardiocel deal even me as it was not the deal I expected . In the process of making this deal I am 100% sure WP has already found at least one prospective partner for the TAVR . Partnering with the TAVR was WP main objective over the last 6 mths , I would suggest the fact no human trials have been done was the main stumbling block . Now AHZ has the funds to complete human trials . If AHZ has successful trials I would not be surprised if WP already has a number of deals on the table . Over the last few weeks I have seen another company I have shares in start to rise from the ashes OSL. , It does happen , I did a similar thing as I did here and bought up big while the SP was tanked out . Let’s hope WP and the board have learnt from previous mistakes. ( not done intentionally ) and AHZ goes on to be the company we all thought it could be . After all the slagging on WP and the board ( some of it deserved ) over the last 12 mths I hope everyone realises they are only human and everyone makes mistakes . WP and the board have done the right thing by all the RI over the last months by putting the companies shares in suspension ( all though some cant see it ) . The SP would have tanked while negotiations were going on and I feel would have led to the company being taken over. ( WP saw that coming ) Hopefully good times lay ahead for AHZ. GLTATH
Expand
IMO, AHZ has already done a "resurrection" as it's now has a MC slightly below that of a start-up biotech company which has secured it's funding without a CR for 2 years if it can sustain the $3M per quarterly loss (along with return from R&D within those 2 years). I think AHZ can get it down to $2M with better revenue from ADAPT and more cost reduction, if the market see this I think a MC of $100M is it's true valuation.
(20min delay)